Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements.
Benjamin J BehersJulian MelchorBrett M BehersZhuo MengPalmer J SwansonHunter I PatersonSamuel J Mendez AraqueJoshua L DavisCameron J GerholdRushabh S ShahAnthony J ThompsonBinit S PatelRoxann W MouratidisMichael J SweeneyPublished in: Nutrients (2023)
Hypertension is the leading preventable risk factor for cardiovascular disease and all-cause mortality worldwide. However, studies have shown increased risk of mortality from heart disease and stroke even within the normal blood pressure (BP) range, starting at BPs above 110-115/70-75 mm Hg. Nutraceuticals, such as vitamins and minerals, have been studied extensively for their efficacy in lowering BP and may be of benefit to the general, normotensive population in achieving optimal BP. Our study investigated the effects of six nutraceuticals (Vitamins: C, D, E; Minerals: Calcium, Magnesium, Potassium) on both systolic blood pressure (SBP) and diastolic blood pressure (DBP) in this population. We performed a systematic review and pairwise meta-analysis for all six supplements versus placebo. Calcium and magnesium achieved significant reductions in both SBP and DBP of -1.37/-1.63 mm Hg and -2.79/-1.56 mm Hg, respectively. Vitamin E and potassium only yielded significant reductions in SBP with values of -1.76 mm Hg and -2.10 mm Hg, respectively. Vitamins C and D were not found to significantly lower either SBP or DBP. Future studies should determine optimal dosage and treatment length for these supplements in the general, normotensive population.
Keyphrases
- type diabetes
- blood pressure
- cardiovascular disease
- hypertensive patients
- glycemic control
- heart rate
- fluorescent probe
- systematic review
- aqueous solution
- living cells
- heart failure
- blood glucose
- case control
- left ventricular
- atrial fibrillation
- cardiovascular events
- emergency department
- clinical trial
- pulmonary hypertension
- high resolution
- metabolic syndrome
- multidrug resistant
- cardiovascular risk factors
- combination therapy
- drug induced
- study protocol